Evidence map›Paper›PMID 28281686›Full record

ArticleScientific reports2017

Auto-phosphorylation Represses Protein Kinase R Activity.

Die Wang, Nicole A de Weerd, Belinda Willard, Galina Polekhina, Bryan R G Williams, Anthony J Sadler

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Inhibition of PKR by Viruses.Frontiers in microbiology · 2021
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Die WangCentre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia.
Nicole A de WeerdCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia.
Belinda WillardProteomics and Metabolomics Laboratory, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, 44195, USA.
Galina PolekhinaCentre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia.
Bryan R G WilliamsCentre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia.
Anthony J SadlerCentre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia.
Hudson Institute of Medical Research · AUMonash University · AUCleveland Clinic Lerner College of Medicine · US

Funding

REGULATION OF INTERFERON-INDUCED DSRNA-ACTIVATED KINASER01AI034039 · NIAID · MONASH UNIVERSITY · PI WILLIAMS, BRYAN R. G. · 1993 to 2008
$2.5M
NIAID NIH HHS R01 AI034039
6 · The paper itself

Abstract

The central role of protein kinases in controlling disease processes has spurred efforts to develop pharmaceutical regulators of their activity. A rational strategy to achieve this end is to determine intrinsic auto-regulatory processes, then selectively target these different states of kinases to repress their activation. Here we investigate auto-regulation of the innate immune effector protein kinase R, which phosphorylates the eukaryotic initiation factor 2α to inhibit global protein translation. We demonstrate that protein kinase R activity is controlled by auto-inhibition via an intra-molecular interaction. Part of this mechanism of control had previously been reported, but was then controverted. We account for the discrepancy and extend our understanding of the auto-inhibitory mechanism by identifying that auto-inhibition is paradoxically instigated by incipient auto-phosphorylation. Phosphor-residues at the amino-terminus instigate an intra-molecular interaction that enlists both of the N-terminal RNA-binding motifs of the protein with separate surfaces of the C-terminal kinase domain, to co-operatively inhibit kinase activation. These findings identify an innovative mechanism to control kinase activity, providing insight for strategies to better regulate kinase activity.

Indexed as

Amino Acid SequenceBinding SitesCloning, MoleculareIF-2 KinaseEscherichia coliEukaryotic Initiation Factor-2Gene ExpressionGenetic VectorsHumansImmunity, InnateModels, MolecularPhosphorylationProtein BindingProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandProtein Interaction Domains and MotifsEIF2AK2 protein, humaneIF-2 KinaseEukaryotic Initiation Factor-2Recombinant Fusion ProteinsRecombinant Proteins

Identifiers

PMID28281686
PMCPMC5345052
OpenAlexW2594922842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.